To 10 ml of human serum diluted 1 : 10 were added 5 mg of lyophilized human hemoglobin, and10 mg dry weight of CM-Sephadex (Pharmacia Fine Chemicals, Sweden). The mixture was packedin cellulose tube (Visking, U.S.A.) and dialyzed against about 100 times volume of 0.01M monobasic sodium phosphate solution, pH approximately 6, stirring on a magnetic stirrerfor 2 hr. When equilibrium was established, hemoglobin was completely adsorbedwith CM-Sephadex. The mixture was centrifuged at 2,000 rpm for 3 min and the supernatant was removed.
The hemoglobin concentration of the supernatant was checked asfollows: Spectrophotometric measurements of the adsorbed serum and the control serum which was added with only hemoglobin showed that hemoglo bin was scarcely contained in the adsorbed serum (Fig. 1) . The adsorbed serum wastested with anti-hemoglobin serum (precipitinogen titer 1: 64,000) by the ring test. Dilution of the serum up to 8 times showed positive reaction.
From this results, the hemoglobin concentration in the adsorbed serum was estimated to be approximately 0.005 mg/ml. In the same way, anti-M and -N sera containing some amount of hemoglobin were adsorbed with CM-Sephadex.
This treatment was performed also on the rabbit antiserum to feta hemoglobin which was adsorbed with adult hemoglobin.
These results revealed that No absorption peak (576 nm) due to hemoglobin is noted in the treated antiserum.
serological activities of the antisera were scarcely affected by the treatment.
Little change was observed on the pattern of disc electrophoretic analyses of the antisera. The adsorbed antisera were available for precipitation without adjustments of pH and molarity.
It was concluded that the CM-Sephadex treatmentto remove hemoglobin from antiserum isuseful in immunohematology.
